Physician Resources
Recently Added |view more
HER2-Targeted Agents: Not Just for Breast Cancer
With 20% of breast cancers driven by alterations to the HER2 gene, inhibiting the expression of this gene has been an objective of researchers and clinicians for decades, and a number of inhibitory therapies have been developed.
Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center
Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly ...
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be ...
Fox Chase Fellows – Winter 2024
People say you never really leave Fox Chase. Just ask Matt Zibelman, MD, who was a Fox Chase hematology/oncology fellow and now is the GU Service Line Director of Clinical and Translational Research—or his colleague Mark Hallman, MD, PhD, ...
In May 2023, Michael O. Meyers, MD, a surgical oncologist at UNC, was named the James F. and Alice B. Newsome Distinguished Professor.
Nosayaba Enofe, MD, presented his experience with a unique minimally invasive hybrid approach to esophagectomy at the American College of Surgeons Clinical Congress.
New Directions in the Diagnosis and Treatment of Hematologic Cancers
DATE: Tuesday, April 16, 2024
Inspiring Residents to Climb Higher
When asked why he chose Fox Chase Cancer Center for his urologic surgery fellowship (2019-2021), Marshall Strother, MD, responds, “I liked the way ‘Fox,’ as he calls Fox Chase, has an exacting, intentional, and deliberate method of training. ...
Celebrate Our Anniversary with Your Vote.
This year, Fox Chase Cancer Center celebrates our 50th anniversary of excellence in cancer care and our 50th year as a National Cancer Institute-designated Comprehensive Cancer Center. This anniversary is a special time to thank our brilliant ...